Gravol (Dimenhydrinate) Pediatric Dose Calculator
Estimate dimenhydrinate pediatric doses for motion sickness and convert mg/kg targets into practical liquid, chewable, or tablet doses.
dose calculator basics
Dimenhydrinate pediatric dose calculator details
Use this Dimenhydrinate calculator as the fast parent page for weight-based dose checks, mL conversion, common strengths, and the practical safety steps that generic calculator sites often skip.
Formula
mL per dose = (child weight in kg x prescribed mg/kg/day / doses per day) / medication concentration in mg per mL.
Worked example
For a 20 kg child using 4 mg/kg/day divided 3 times daily with 12.5 mg/5 mL, calculate the daily mg target, divide by the schedule, then convert that mg amount into mL for the selected product.
Safety checks before using the result
- Use the exact product strength in hand before measuring the dose.
- Confirm maximum dose, age limits, and indication-specific cautions when they apply.
- Escalate urgent symptoms or medication reactions instead of repeating doses from calculator output alone.
Practical dosing guide
Before you measure the dose
Use this page to confirm the dose, the form in hand, and the redosing plan before giving Dimenhydrinate.
- What it helps with
- Dimenhydrinate is an antihistamine used in children for motion sickness and selected nausea plans.
- Common forms
- Common forms include 12.5 mg/5 mL liquid, 15 mg/5 mL liquid (Kids Gravol, Canada), and 25 mg chewable.
- How the schedule is usually written
- About 1 mg/kg per dose every 6 hours, capped by age.
Dimenhydrinate pediatric medication summary
Dimenhydrinate is an antihistamine used in children for motion sickness and selected nausea plans. Use the pediatric dose calculator to match child dosing to the trip schedule and common liquid or chewable forms.
Administer 30–60 minutes before travel and repeat every 6 hours as needed (≈1 mg/kg/dose, capped by age: max 75 mg/day at 2–5 years, 150 mg/day at 6–11 years, 400 mg/day at 12 and up); do a supervised test dose before major trips.
Expect sedation and possible paradoxical agitation—plan quiet activities and avoid sports requiring balance after dosing.
Dimenhydrinate indications and common pediatric uses
Dimenhydrinate is a first-generation antihistamine used for short-term prevention or rescue of vestibular-related nausea when timing and supervision are reliable.
Motion sickness prophylaxis
Motion sickness prophylaxis: Best for predictable travel triggers; avoid daily long-term use.
Acute vestibular neuritis/labyrinthitis
Acute vestibular neuritis/labyrinthitis: Stop once nausea resolves and focus on vestibular therapy.
Postoperative nausea and vomiting (PONV)
Postoperative nausea and vomiting (PONV): Adjunct option when standard prophylaxis is insufficient.
Cyclic vomiting syndrome rescue therapy
Cyclic vomiting syndrome rescue therapy: Use as part of a defined rescue plan and document response.
Migraine-associated nausea
Migraine-associated nausea: Escalate to neurology for frequent migraines or refractory nausea.
Hyperemesis gravidarum (specialist-directed)
Hyperemesis gravidarum (specialist-directed): Use only with obstetric oversight in pregnant adolescents.
How to give Dimenhydrinate
- Administration guidance for pediatric dimenhydrinate.
- For prophylaxis, administer 30–60 minutes prior to travel and then every 6 hours as needed. Liquids can be mixed with juice to mask taste. Avoid concurrent alcohol-containing products.
- Sedation is common—plan quiet activities and avoid operating bicycles or scooters when drowsy. For nocturnal dosing, ensure safe sleeping arrangements.
Dimenhydrinate side effects, contraindications, and interactions
Dimenhydrinate commonly causes drowsiness and other anticholinergic effects, and some younger children may have paradoxical agitation instead of sedation. Most reactions are mild, but families should know clear stop and escalation triggers. Call your pediatric clinician for persistent vomiting, poor intake, urinary problems, or behavior changes. Seek urgent care for breathing difficulty, severe confusion, inability to wake, or seizure-like activity.
Common side effects
- Use the lowest effective dose and limit therapy to short courses for motion sickness or vestibular nausea.
- Avoid concurrent sedatives (including duplicate antihistamines, opioids, or benzodiazepines), and counsel older adolescents about alcohol-containing products.
- Monitor for paradoxical agitation, especially in toddlers and children with neurodevelopmental conditions.
Safety checks
- Asthma or chronic lower airway disease: Sedation and thickened secretions can worsen ventilation.
- Seizure disorder: First-generation antihistamines may lower seizure threshold.
- Severe drowsiness, confusion, or trouble breathing: Sedation can progress to respiratory depression.
- Inability to urinate or severe eye pain: Anticholinergic effects can precipitate acute crises.
- Hallucinations or severe agitation: CNS toxicity is more common with first-generation antihistamines.
Drug interactions
- Review the full medication list with a clinician or pharmacist before combining therapies.
Dimenhydrinate mechanism and clinical pearls
Dimenhydrinate combines diphenhydramine with 8-chlorotheophylline and is used mainly for short-term prevention or treatment of motion-related nausea. Diphenhydramine reduces vestibular and emetic pathway signaling through central H1 and muscarinic blockade. The 8-chlorotheophylline component may blunt some sedation, but clinically meaningful drowsiness still occurs in many children. Practical value comes from pre-trigger timing, conservative dosing, and early reassessment when response is incomplete.
Give 30-60 minutes before travel for predictable triggers; if needed, repeat per label/prescriber instructions (often every 6 hours). Waiting for severe nausea lowers benefit.
Use age/weight-based dosing from product labeling or prescriber instructions (commonly around 1 mg/kg per dose, with age-specific maximums of 75 mg/day at 2–5 years, 150 mg/day at 6–11 years, and 400 mg/day at 12 and up). Children under 2 years require direct clinician oversight.
Warn families about drowsiness; avoid bikes, scooters, or swimming until they know the child's response.
Young children can become agitated or hallucinate; hold additional doses and contact a clinician if behavior changes.
Frequently asked questions about Dimenhydrinate
Give the first dose 30–60 minutes before the trip so the medicine is active when motion begins. If the trip lasts longer than 6 hours, you can give another dose as instructed by your clinician.
Use the calculator with your child’s weight, age, and the product strength you have on hand. This helps translate the travel plan into a practical liquid, chewable, or tablet dose before the trip starts.
Sleepiness is common. Provide a safe napping environment and avoid activities that require coordination, such as biking or climbing. If sedation is excessive or your child becomes difficult to wake, contact your clinician.
Avoid using it with other products that cause drowsiness (cold medicines, diphenhydramine, sleep aids) unless your clinician approves. Always share a list of all medications and supplements before dosing.
Try non-pharmacologic strategies (fresh air, horizon focus, frequent breaks) and offer small sips of oral rehydration solution. If vomiting persists beyond 24 hours, or signs of dehydration appear, seek medical care.
Yes, but track each dose to avoid exceeding the maximum daily amount. Use calm bedtime routines because the medicine can cause either sleepiness or, rarely, restlessness in young children.
Yes, once the child is alert and symptoms are controlled. Inform teachers or counselors about possible drowsiness and provide instructions for dosing if a follow-up dose is needed during the day.
Seek urgent care for breathing problems, severe agitation, confusion, seizures, hallucinations, or difficulty urinating. Bring the medication bottle so clinicians know the amount taken.
Sources reviewed for Dimenhydrinate
cdc-yellowbook-motion-sickness-2024
uptodate-vertigo-management-2024
anesthesiology-ponv-2014
statpearls-cyclic-vomiting-2024
cephalalgia-migraine-nausea-2022
acog-nvp-2018